Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care Clinical presentation, diagnosis, and management

BMC Family Practice

Volumn 16, Issue 1, 2015, Pages

  Al Ani, Salwan ^a   Spigt, Mark ^a,b   Laue, Johanna ^a   Melbye, Hasse ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antibiotics; Asthma; COPD; Exacerbations; Systemic corticosteroids

Indexed keywords

EID: 84928335186     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-015-0256-3     Document Type: Article

References (35)

1. Rabe KF, Wedzicha JA. Controversies in treatment of chronic obstructive pulmonary disease. Lancet. 2011;378:1038-47.
2. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-50.
3. Melbye H, Drivenes E, Dalbak LG, Leinan T, Hoegh-Henrichsen S, Ostrem A. Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis. 2011;6:597-603.
4. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59-99.
5. The Norwegian Ministry of health. The Norwegian public health strategis for prevention and management of asthma and allergic diseases. Published May 2008. Publication code I-1134 B. 2014.
6. Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101:481-9.
7. Al-ani S, Spigt M, Hofset P, Melbye H. Predictors of exacerbations of asthma and COPD during one year in primary care. Fam Pract. 2013;30:621-8.
8. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128-38.
9. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672-88.
10. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-92.
11. Pearson M, Ayres JG, Sarno M, Massey D, Price D. Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997-2001. Int J Chron Obstruct Pulmon Dis. 2006;1:435-43.
12. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global strategy for the diagnosis, mamagement, and prevention of chronic obstructive pulmonary disease (revised 2011). 31-1-2012. [ http://www.goldcopd.org/guidlines-global-strategy-for-diagnosis-management.html ]
13. Miravitlles M. [Treatment failure of acute exacerbations of chronic obstructive airways disease risk factors and clinical relevance]. Med Clin (Barc). 2002;119:304-14.
14. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204.
15. Blasi F, Ewig S, Torres A, Huchon G. A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis. Pulm Pharmacol Ther. 2006;19:361-9.
16. Management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010. [http:,guidance.nice.org.uk/CG101]
17. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet. 1999;353:364-9.
18. The global initiative for asthma. 2012. [ http://www.ginasthma.org ]
19. Pollart SM, Compton RM, Elward KS. Management of acute asthma exacerbations. Am Fam Physician. 2011;84:40-7.
20. Roede BM, Bindels PJE, Brouwer HJ, Bresser P, de Borgie CAJM, Prins JM. Antibiotics and Steroids for Exacerbations of COPD in Primary Care: Compliance with Dutch Guidelines. Br J Gen Pract. 2006;56(530):662-5.
21. Llor C, Bjerrum L, Munck A, Hansen MP, Córdoba GC, Strandberg EL, et al. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice. Ther Adv Respir Dis. 2013;7:131-7.
22. Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
23. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994;150:11-6.
24. Similowski T, Suissa S. Systemic steroids in severe forms of COPD exacerbations: a question of balance? Eur Respir J. 2014;43:668-70.
25. Miller MR, Hankinson J, Brusasco V, Casaburi R, Coates A, Crapo R, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-38.
26. Macfarlane J, Lewis SA, Macfarlane R, Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: implications for developing management duidelines. Respir Med. 1997;91(7):427-34.
27. Hopstaken RM, Butler CC, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, et al. Do clinical findings in lower respiratory tract infection help general practitioners prescribe antibiotics appropriately? An observational cohort study in general practice. Fam Pract. 2006;23:180-7.
28. Jakobsen KA, Melbye H, Kelly MJ, Ceynowa C, Mölstad S, Hood K, et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care. 2010;28:229-36.
29. Coenen S, Van RP, Vermeire E, Hermann I, Denekens J. Antibiotics for coughing in general practice: a qualitative decision analysis. Fam Pract. 2000;17:380-5.
30. Butler CC, Rollnick S, Kinnersley P, Jones A, Stott N. Reducing antibiotics for respiratory tract symptoms in primary care: consolidating 'why' and considering 'how'. Br J Gen Pract. 1998;48:1865-70.
31. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ. 2009;338:b1374.
32. Sundh J, Osterlund EE, Janson C, Montgomery S, Stallberg B, Lisspers K. Management of COPD exacerbations in primary care: a clinical cohort study. Prim Care Respir J. 2013;22:393-9.
33. Bradley CP. Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. Br J Gen Pract. 1992;42:454-8.
34. Haugen T, Bakken IJ, Storro O, Oien T, Langhammer A. Utilization of diagnostic tools and health care services for obstructive lung disease. Tidsskr Nor Laegeforen. 2008;128:2431-4.
35. Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol. 2009;9:4-9.416.